Stocks and Investing Stocks and Investing
Mon, August 14, 2017
Fri, August 11, 2017

Christopher Marai Maintained (SNDX) at Strong Buy with Decreased Target to $22 on, Aug 11th, 2017


Published on 2024-10-25 22:18:22 - WOPRAI, Christopher Marai
  Print publication without navigation


Christopher Marai of Nomura, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Decreased Target from $27 to $22 on, Aug 11th, 2017.

Christopher, nor any peers, have made any analyst calls on SNDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources